Glutamate alteration of glutamic acid decarboxylase (GAD) in GABAergic neurons: The role of cysteine proteases

Experimental Neurology

Volumn 213, Issue 1, 2008, Pages 145-153

  Monnerie, Hubert ^a   Le Roux, Peter D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Calpain; Cathepsin; Cerebral cortex; Excitotoxicity; GABA; GAD; Glutamate; Neuron

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CALCIUM ION; CALPAIN; CATHEPSIN PROTEASE; CYSTEINE PROTEINASE; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; N ACETYLLEUCYLLEUCYLNORLEUCINAL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEINASE; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BRAIN NERVE CELL; CALCIUM TRANSPORT; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME ASSAY; EXCITOTOXICITY; EXTRACELLULAR CALCIUM; MOUSE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; WESTERN BLOTTING;

ANIMALS; BRAIN DAMAGE, CHRONIC; CALCIUM SIGNALING; CALPAIN; CATHEPSINS; CELLS, CULTURED; CEREBRAL CORTEX; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; ENZYME ACTIVATION; EPILEPSY; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; HYPOXIA-ISCHEMIA, BRAIN; MICE; MICE, INBRED BALB C; NEURONS; NEUROTOXINS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 49349116481     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2008.05.013     Document Type: Article

References (56)

1. Adamec E., Beermann M.L., and Nixon R.A. Calpain I activation in rat hippocampal neurons in culture is NMDA receptor selective and not essential for excitotoxic cell death. Mol. Brain Res. 54 (1998) 35-48
2. Akashiba H., Matsuki N., and Nishiyama N. Calpain activation is required for glutamate-induced p27 down-regulation in cultured cortical neurons. J. Biol. Chem. 99 (2006) 733-744
3. Asada H., Kawamura Y., Maruyama K., Kume H., Ding R., Kanbara N., Kuzume H., Sanbo M., Yagi T., and Obata K. Cleft palate and decreased brain γ-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 6496-6499
4. Bao J., Cheung W.Y., and Wu J.Y. Brain l-glutamate decarboxylase. J. Biol. Chem. 270 (1995) 6464-6467
5. Boland B., and Campbell V. Aβ-mediated activation of the apoptotic cascade in cultured cortical neurones: a role for cathepsin L. Neurobiol. Aging 25 (2004) 83-91
6. Brorson J.R., Marcuccilli C.J., and Miller R.J. Delayed antagonism of calpain reduces excitotoxicity in cultured neurons. Stroke 26 (1995) 1259-1266
7. Centonze D., Marfia G.A., Pisani A., Picconi B., Giacomini P., Bernardi G., and Calabresi P. Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons. Prog. Neurobiol. 63 (2001) 687-696
8. Cortez S.C., Mcintosh T.K., and Noble L.J. Experimental fluid percussion brain injury: vascular disruption and neuronal and glial alterations. Brain Res. 482 (1989) 271-282
9. Fatemi S.H., Halt A.R., Stary J.M., Kanodia R., Schultz S.C., and Realmuto G.R. Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol. Psych. 52 (2002) 805-810
10. Figueiredo-Pereira M.E., Banik N., and Wilk S. Comparison of the effect of calpain inhibitors on two extralysosomal proteinases: the multicatalytic proteinase complex and m-calpain. J. Neurochem. 62 (1994) 1989-1994
11. Goll D.E., Thompson V.F., Li H., Wei W., and Cong J. The calpain system. Physiol. Rev. 83 (2003) 731-801
12. Graber S., Maiti S., and Halpain S. Cathepsin B-like proteolysis and MARCKS degradation in sub-lethal NMDA-induced collapse of dendritic spines. Neuropharmacology 47 (2004) 706-713
13. 2 deprivation in the central nervous system: on the mechanisms of neuronal response, differential sensitivity and injury. Prog. Neurobiol. 40 (1993) 277-318
14. Hajimohammadreza I., Raser K.J., Nath R., Nadimpalli R., Scott M., and Wang K.K.W. Neuronal nitric oxide synthase and calmodulin-dependent protein kinase IIα undergo neurotoxin-induced proteolysis. J. Neurochem. 69 (1997) 1006-1013
15. Hiwasa T., Sawada T., and Sakiyama S. Cysteine proteinase inhibitors and ras gene products share the same biological activities including transforming activity toward NIH3T3 mouse fibroblasts and the differentiation-including activity toward PC12 rat pheochromocytoma cells. Carcinogenesis 11 (1990) 75-80
16. Husi H., Ward M.A., Choudhary J.S., Blackstock W.P., and Grant S.G.N. Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat. Neurosci. 3 (2000) 661-669
17. Katayama Y., Becker D.P., Tamura T., and Hovda D.A. Massive increases in extracellular potassium and indiscriminate release of glutamate following concussive brain injury. J. Neurosurg. 73 (1990) 889-900
18. Kitao Y., Ozawa K., Miyazaki M., Tamatani M., Kobayashi T., Yanagi H., Okabe M., Ikawa M., Yamashima T., Stern D.M., Hori O., and Ogawa S. Expression of the endoplasmic reticulum molecular chaperone (ORP150) rescues hippocampal neurons from glutamate toxicity. J. Clin. Invest. 108 (2001) 1439-1450
19. Kohda Y., Yamashima T., Sakuda K., Yamashita J., Ueno T., Kominami E., and Yoshioka T. Dynamic changes of cathepsin B and L expression in the monkey hippocampus after transient ischemia. Biochem. Biophys. Res. Commun. 228 (1996) 616-622
20. Lee J.M., Grabb M.C., Zipfel G.J., and Choi D.W. Brain tissue responses to ischemia. J. Clin. Invest. 106 (2000) 723-731
21. Litersky J.M., and Johnson G.V. Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain. J. Biol. Chem. 267 (1992) 1563-1568
22. Lowenstein D.H., Thomas M.J., Smith D.H., and Mcintosh T.K. Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head trauma and disorders of the hippocampus. J. Neurosci. 12 (1992) 4846-4853
23. Manor D., Rothman D.L., Mason G.F., Hyder F., Petroff O.A.C., and Behar K.L. The rate of turnover of cortical GABA from [1-C-13]glucose is reduced in rats treated with the GABA-transaminase inhibitor vigabatrin (gamma-vinyl GABA). Neurochem. Res. 21 (1996) 1031-1041
24. Monnerie H., and Le Roux P. Reduced dendrite growth and altered glutamic acid decarboxylase (GAD) 65- and 67-kDa isoform protein expression from mouse cortical GABAergic neurons following excitotoxic injury in vitro. Exp. Neurol. 205 (2007) 367-382
25. Najlerahim A., and Pearson R.C.A. Changes in glutamic acid decarboxylase mRNA in the pallidum of the rat following unilateral damage of the striatum and overlying cortex. Exp. Neurol. 118 (1992) 352-356
26. Najlerahim A., Williams S.F., Pearson R.C.A., and Jefferys J.G.R. Increased expression of GAD mRNA during the chronic epileptic syndrome due to intrahippocampal tetanus toxin. Exp. Brain Res. 90 (1992) 332-342
27. Nakamura Y., Takeda M., Suzuki H., Hattori H., Tada K., Hariguchi S., Hashimoto S., and Nishimura T. Abnormal distribution of cathepsins in the brain of Alzheimer's disease patients. Neurosci. Lett. 130 (1991) 195-198
28. Namchuk M., Lindsay L., Turck C.W., Kanaani J., and Baekkeskov S. Phosphorylation of serine residues 3, 6, 10 and 13 distinguishes membrane anchored from soluble glutamic acid decarboxylase 65 and is restricted to glutamic acid decarboxylase 65a. J. Biol. Chem. 272 (1997) 1548-1557
29. Neder L., Valente V., and Carlotti C.G. Glutamate NMDA receptor subunit R1 and GAD mRNA expression in human temporal lobe epilepsy. Cell Mol. Neurobiol. 22 (2002) 689-698
30. Nixon R.A., Mathews P.M., and Cataldo A.M. The neuronal endosomal-lysosomal system in Alzheimer's disease. J. Alzheimer's Dis. 3 (2001) 97-107
31. Obenaus A., Esclapez M., and Hauser C.R. Loss of glutamate decarboxylase mRNA-containing neurons in the rat dentate gyrus following pilocarpine-induced seizures. J. Neurosci. 13 (1993) 4470-4485
32. Olney J.W., Collins R.C., and Sloviter R.S. Excitotoxic mechanisms of epileptic brain damage. Adv. Neurol. 44 (1986) 857-877
33. Pulsinelli W.A. Selective neuronal vulnerability: morphological and molecular characteristics. Prog. Brain Res. 63 (1985) 29-37
34. Ribak C.E., Harris A.B., Vaughn J.E., and Roberts E. Inhibitory, GABAergic nerve terminals decrease at sites of focal epilepsy. Science 205 (1979) 211-214
35. Sheng M., and Lee S.H. Growth of the NMDA receptor industrial complex. Nat. Neurosci. 3 (2000) 633-635
36. Shetty A.K., and Turner D.A. Fetal hippocampal grafts containing CA3 cells restore host hippocampal glutamate decarboxylase-positive interneuron numbers in a rat model of temporal lobe epilepsy. J. Neurosci. 20 (2000) 8788-8801
37. Siman R., and Noszek J.C. Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron 1 (1988) 279-287
38. Siman R., Noszek J.C., and Kegerise C. Calpain I activation is specifically related to excitatory amino-acid induction of hippocampal damage. J. Neurosci. 9 (1989) 1579-1590
39. Simmons G., Gosalia D.N., Rennekamp A.J., Reeves J.D., Diamond S.L., and Bates P. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 11876-11881
40. Simon R.P., Griffiths T., Evans M.C., Swan J.H., and Meldrum B.S. Calcium overload in selectively vulnerable neurons in the hippocampus during and after ischemia: and electron microscopy study in the rat. J. Cereb. Blood Flow Metab. 4 (1984) 350-361
41. Soghomonian J.-J., and Martin D.L. Two isoforms of glutamate decarboxylase: why?. TIPS 19 (1998) 500-505
42. Tecoma E.S., and Choi D.W. GABAergic neocortical neurons are resistant to NMDA receptor-mediated injury. Neurology 39 (1989) 676-682
43. Torrey E.F., Barci B.M., Webster M.J., Bartko J.J., Meador-Woodruff J.H., and Knable M.B. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in portmortem brains. Biol. Psychiatry 57 (2005) 252-260
44. Tsuchiya K., Kohda Y., Yoshida M., Zhao L., Ueno T., Yamashita J., Yoshioka T., Kominam E., and Yamashima T. Postictal blockade of ischemic hippocampal neuronal death in primates using selective cathepsin inhibitors. Exp. Neurol. 155 (1999) 187-194
45. Wang K.K.W. Developing selective inhibitors of calpain. Trends Pharmacol. Sci. 11 (1990) 139-142
46. Wu H., and Lynch D.R. Calpain and synaptic function. Mol. Neurobiol. 33 (2006) 215-236
47. Wu H.Y., Tomizawa K., Oda Y., Wei F.Y., Lu Y.F., Matsushita M., Li S.T., Moriwaki A., and Matsui H. Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. J. Biol. Chem. 279 (2004) 4929-4940
48. Wu H.Y., Yuen E.Y., Lu Y.F., Matsushita M., Matsui H., Yan Z., and Tomizawa K. Regulation of N-methyl-d-aspartate receptors by calpain in cortical neurons. J. Biol. Chem. 280 (2005) 21588-21593
49. Yamashima T. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog. Neurobiol. 62 (2000) 273-295
50. 2+-dependent proteases in ischemic neuronal death. A conserved 'calpain-cathepsin cascade' from nematodes to primates. Cell Calcium 36 (2004) 285-293
51. Yamashima T., Kohda Y., Tsuchiya K., Ueno T., Yamashita J., Yoshioka T., and Kominami E. Inhibition of ischemic hippocampal neuronal death in primates with cathepsin B inhibitor CA-074: a novel strategy for neuroprotection based on 'calpain-cathepsin hypothesis'. Eur. J. Neurosci. 10 (1998) 1723-1733
52. Yamashima T., Tonchev A.B., Tsukada T., Saido T.C., Imajoh-Ohmi S., Momoi T., and Kominami E. Sustained calpain activation associated with lysosomal rupture executes necrosis of the postischemic CA1 neurons in primates. Hippocampus 13 (2003) 791-800
53. Yoshida M., Yamashima T., Zhao L., Tsuchiya K., Kohda Y., Tonchev A.B., Matsuda M., and Kominami E. Primate neurons show different vulnerability to transient ischemia and response to cathepsin inhibition. Acta Neuropathol. 104 (2002) 267-272
54. Yoshiyama Y., Arai K., Oki T., and Hattori T. Expression of invariant chain and pro-cathepsin L in Alzheimer's brain. Neurosci. Lett. 290 (2000) 125-128
55. Zakharov V., and Mosevitsky M.I. M-calpain-mediated cleavage of GAP-43 near Ser41 is negatively regulated by protein kinase C, calmodulin and calpain-inhibiting fragment GAP-43-3. J. Neurochem. 101 (2007) 1539-1551
56. Zhang Z., Ottens A.K., Sadasivan S., Kobeissy F.H., Fang T., Hayes R.L., and Wang K.K.W. Calpain-mediated collapsin response mediator protein-1, -2, and -4 proteolysis after neurotoxic and traumatic brain injury. J. Neurotrauma 24 (2007) 460-472